Research Article
BibTex RIS Cite

Retrospective Evaluation of Placenta Previa Cases: A Secondary-center Experince

Year 2020, Volume: 8 Issue: 2, 197 - 203, 23.08.2020
https://doi.org/10.37696/nkmj.653185

Abstract

Abstract
Aim: The aim of this study was to retrospectively evaluate the maternal and neonatal outcomes of placenta previa cases managed in our hospital.
Material and methods: The records of 107 placenta previa cases delivered between 2010 and 2015 were retrospectively reviewed. Age, gravida, parity, red blood cell (RBC)-fresh frozen plasma (FFP) transfusion necessity, gestational week at birth, birth weight, 1st and 5th minute Apgar score, number of previous cesarean sections, requiring additional surgical intervention (Hypogastric artery ligation [HAL], peripartum hysterectomy) and maternal complications were examined.
Results: RBC-FFP transfusion and HAL rates were significantly higher incomplete placenta previa cases than the partial placenta previa cases. RBC-TDP transfusion, HAL and peripartum hysterectomy rates were significantly higher in placenta accreata spectrum (PAS) cases compared to those cases with normal placental invasion. Prematurity risk increased in all placenta previa subgroups.
Conclusion: Pregnancy complicated by placenta previa increases the risk of adverse maternal and neonatal outcomes, especially if there is a concomitant placental invasion anomaly.
Keywords: Placenta previa, Placenta accreata spectrum, Hypogastric artery ligation, Peripartum hysterectomy.

Supporting Institution

yok

References

  • References 1. Durukan H, Durukan ÖB, Yazıcı FG. Planned versus urgent deliveries in placenta previa: maternal, surgical and neonatal results. Arch Gynecol Obstet. 2019;
  • 2. Kollmann M, Gaulhofer J, Lang U, Klaritsch P. Placenta previa: incidence, risk factors and outcome. J Matern Fetal Neonatal Med. 2016;29(9):1395-8.
  • 3. Solheim KN, Esakoff TF, Little SE, Cheng YW, Sparks TN, Caughey AB. The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreata, and maternal mortality. J Matern Fetal Neonatal Med. 2011;24(11):1341-6.
  • 4. Matalliotakis M, Velegrakis A, Goulielmos GN, Niraki E, Patelarou AE, Matalliotakis I. Association of Placenta Previa with a History of Previous Cesarean Deliveries and Indications for a Possible Role of a Genetic Component. Balkan J Med Genet. 2017;20(2):5-10.
  • 5. Karami M, Jenabi E, Fereidooni B. The association of placenta previa and assisted reproductive techniques: a meta-analysis. J Matern Fetal Neonatal Med. 2018;31(14):1940-47.
  • 6. Rosenberg T, Pariente G, Sergienko R, Wiznitzer A, Sheiner E. Critical analysis of risk factors and outcome of placenta previa. Arch Gynecol Obstet. 2011;284(1):47-51.
  • 7. Jauniaux E, Alfirevic Z, Bhide AG, et al. Placenta previa and Placenta Accreata: Diagnosis and Management: Green-top Guideline No. 27.a. BJOG. 2019;126(1):e1-e48.
  • 8. Jauniaux E, Bhide A, Kennedy A, et al. FIGO consensus guidelines on placenta accreata spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018;140(3):274-80.
  • 9. Roustaei Z, Vehvilӓinen-Julkunen K, Tuomainen TP, Lamminpӓӓ R, Heinonen S. The effect of advanced maternal age on maternal and neonatal outcomes of placenta previa: A register-based cohort study. Eur J Obstet Gynecol Reprod Biol. 2018;227:1-7.
  • 10. Porreco RP, Stettler RW. Surgical remedies for postpartum hemorrhage. Clin Obstet Gynecol. 2010;53(1):182-95.
  • 11. Yildiz C, Akkar OB, Karakuş S, Çetin A, Yanik A. Hypogastric artery ligation for obstetrical hemorrhage: clinical experience in a tertiary care center. Turk J Med Sci. 2015;45(6):1312-6.
  • 12. Rauf M, Ebru C, Sevil E, Selim B. Conservative management of post-partum hemorrhage secondary to placenta previa-accreata with hypogastric artery ligation and endo-uterine hemostatic suture. J Obstet Gynaecol Res. 2017;43(2):265-71.
  • 13. Lal AK, Hibbard JU. Placenta previa: an outcome-based cohort study in a contemporary obstetric population. Arch Gynecol Obstet. 2015;292(2):299-305.
  • 14. Sparić R, Mirković L, Ravilić U, Janjić T. Obstetric complications of placenta previa percreata. Vojnosanit Pregl. 2014;71(12):1163-6.
  • 15. Ahmed SR, Aitallah A, Abdelghafar HM, Alsammani MA. Major Placenta Previa: Rate, Maternal and Neonatal Outcomes Experience at a Tertiary Maternity Hospital, Sohag, Egypt: A Prospective Study. J Clin Diagn Res. 2015;9(11):QC17-9.
  • 16. Su HW, Yi YC, Tseng JJ, et al. Maternal outcome after conservative management of abnormally invasive placenta. Taiwan J Obstet Gynecol. 2017;56(3):353-7.
  • 17. Tahaoglu AE, Balsak D, Togrul C, Obut M, Tosun O, Cavus Y, et al. Emergency peripartum hysterectomy: our experience. Ir J Med Sci. 2016;185(4):833-838.
Year 2020, Volume: 8 Issue: 2, 197 - 203, 23.08.2020
https://doi.org/10.37696/nkmj.653185

Abstract

References

  • References 1. Durukan H, Durukan ÖB, Yazıcı FG. Planned versus urgent deliveries in placenta previa: maternal, surgical and neonatal results. Arch Gynecol Obstet. 2019;
  • 2. Kollmann M, Gaulhofer J, Lang U, Klaritsch P. Placenta previa: incidence, risk factors and outcome. J Matern Fetal Neonatal Med. 2016;29(9):1395-8.
  • 3. Solheim KN, Esakoff TF, Little SE, Cheng YW, Sparks TN, Caughey AB. The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreata, and maternal mortality. J Matern Fetal Neonatal Med. 2011;24(11):1341-6.
  • 4. Matalliotakis M, Velegrakis A, Goulielmos GN, Niraki E, Patelarou AE, Matalliotakis I. Association of Placenta Previa with a History of Previous Cesarean Deliveries and Indications for a Possible Role of a Genetic Component. Balkan J Med Genet. 2017;20(2):5-10.
  • 5. Karami M, Jenabi E, Fereidooni B. The association of placenta previa and assisted reproductive techniques: a meta-analysis. J Matern Fetal Neonatal Med. 2018;31(14):1940-47.
  • 6. Rosenberg T, Pariente G, Sergienko R, Wiznitzer A, Sheiner E. Critical analysis of risk factors and outcome of placenta previa. Arch Gynecol Obstet. 2011;284(1):47-51.
  • 7. Jauniaux E, Alfirevic Z, Bhide AG, et al. Placenta previa and Placenta Accreata: Diagnosis and Management: Green-top Guideline No. 27.a. BJOG. 2019;126(1):e1-e48.
  • 8. Jauniaux E, Bhide A, Kennedy A, et al. FIGO consensus guidelines on placenta accreata spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018;140(3):274-80.
  • 9. Roustaei Z, Vehvilӓinen-Julkunen K, Tuomainen TP, Lamminpӓӓ R, Heinonen S. The effect of advanced maternal age on maternal and neonatal outcomes of placenta previa: A register-based cohort study. Eur J Obstet Gynecol Reprod Biol. 2018;227:1-7.
  • 10. Porreco RP, Stettler RW. Surgical remedies for postpartum hemorrhage. Clin Obstet Gynecol. 2010;53(1):182-95.
  • 11. Yildiz C, Akkar OB, Karakuş S, Çetin A, Yanik A. Hypogastric artery ligation for obstetrical hemorrhage: clinical experience in a tertiary care center. Turk J Med Sci. 2015;45(6):1312-6.
  • 12. Rauf M, Ebru C, Sevil E, Selim B. Conservative management of post-partum hemorrhage secondary to placenta previa-accreata with hypogastric artery ligation and endo-uterine hemostatic suture. J Obstet Gynaecol Res. 2017;43(2):265-71.
  • 13. Lal AK, Hibbard JU. Placenta previa: an outcome-based cohort study in a contemporary obstetric population. Arch Gynecol Obstet. 2015;292(2):299-305.
  • 14. Sparić R, Mirković L, Ravilić U, Janjić T. Obstetric complications of placenta previa percreata. Vojnosanit Pregl. 2014;71(12):1163-6.
  • 15. Ahmed SR, Aitallah A, Abdelghafar HM, Alsammani MA. Major Placenta Previa: Rate, Maternal and Neonatal Outcomes Experience at a Tertiary Maternity Hospital, Sohag, Egypt: A Prospective Study. J Clin Diagn Res. 2015;9(11):QC17-9.
  • 16. Su HW, Yi YC, Tseng JJ, et al. Maternal outcome after conservative management of abnormally invasive placenta. Taiwan J Obstet Gynecol. 2017;56(3):353-7.
  • 17. Tahaoglu AE, Balsak D, Togrul C, Obut M, Tosun O, Cavus Y, et al. Emergency peripartum hysterectomy: our experience. Ir J Med Sci. 2016;185(4):833-838.
There are 17 citations in total.

Details

Primary Language English
Subjects Clinical Sciences
Journal Section Orginal Article
Authors

Mehmet Obut

Süleyman Cemil Oğlak

Publication Date August 23, 2020
Published in Issue Year 2020 Volume: 8 Issue: 2

Cite

APA Obut, M., & Oğlak, S. C. (2020). Retrospective Evaluation of Placenta Previa Cases: A Secondary-center Experince. Namık Kemal Tıp Dergisi, 8(2), 197-203. https://doi.org/10.37696/nkmj.653185
AMA Obut M, Oğlak SC. Retrospective Evaluation of Placenta Previa Cases: A Secondary-center Experince. NKMJ. August 2020;8(2):197-203. doi:10.37696/nkmj.653185
Chicago Obut, Mehmet, and Süleyman Cemil Oğlak. “Retrospective Evaluation of Placenta Previa Cases: A Secondary-Center Experince”. Namık Kemal Tıp Dergisi 8, no. 2 (August 2020): 197-203. https://doi.org/10.37696/nkmj.653185.
EndNote Obut M, Oğlak SC (August 1, 2020) Retrospective Evaluation of Placenta Previa Cases: A Secondary-center Experince. Namık Kemal Tıp Dergisi 8 2 197–203.
IEEE M. Obut and S. C. Oğlak, “Retrospective Evaluation of Placenta Previa Cases: A Secondary-center Experince”, NKMJ, vol. 8, no. 2, pp. 197–203, 2020, doi: 10.37696/nkmj.653185.
ISNAD Obut, Mehmet - Oğlak, Süleyman Cemil. “Retrospective Evaluation of Placenta Previa Cases: A Secondary-Center Experince”. Namık Kemal Tıp Dergisi 8/2 (August 2020), 197-203. https://doi.org/10.37696/nkmj.653185.
JAMA Obut M, Oğlak SC. Retrospective Evaluation of Placenta Previa Cases: A Secondary-center Experince. NKMJ. 2020;8:197–203.
MLA Obut, Mehmet and Süleyman Cemil Oğlak. “Retrospective Evaluation of Placenta Previa Cases: A Secondary-Center Experince”. Namık Kemal Tıp Dergisi, vol. 8, no. 2, 2020, pp. 197-03, doi:10.37696/nkmj.653185.
Vancouver Obut M, Oğlak SC. Retrospective Evaluation of Placenta Previa Cases: A Secondary-center Experince. NKMJ. 2020;8(2):197-203.